Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 23, 2015
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics Inc
|
0
|
$13.26 |
—
|
—
| 30.69K | +1 |
Jun 19
|
Scheduled
| |||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 1
| ||||||
Amicus Therapeutics Inc
| 5.69K |
$10.82 | -$209,019.60 |
∞
| 5.69K | +1 |
May 8 - May 11
|
Scheduled
| |||||
Amicus Therapeutics Inc
|
0
|
$11.51 |
—
|
—
| 114.05K | +1 |
Mar 20
|
Scheduled
| |||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 2
| ||||||
Amicus Therapeutics Inc
|
0
|
$8.00 |
—
|
—
| 107K | +1 |
Nov 25
|
Scheduled
| |||||
Amicus Therapeutics Inc
|
0
|
$6.00 |
—
|
—
| 107K | +1 |
Aug 25
|
Scheduled
| |||||
Amicus Therapeutics Inc
|
0
|
$5.40 |
—
|
—
| 112.81K | +1 |
Aug 20
|
Scheduled
| |||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 26
| ||||||
Amicus Therapeutics Inc
| 50K |
—
|
—
|
∞
| 50K | +1 |
Apr 10
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 3
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 18
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 28
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 4
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 15
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 16
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 19
| ||||||
Amicus Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |